Adverse Rxn & Molecular Testing Flashcards

1
Q

HLA properties

A
  • Present peptide to TCR (self-recognition & immunological defense)
  • Polymorphic
  • Co-dominant
  • Mendelian rules
  • Ethnical difference
  • Patient create Abs against HLA protein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

HLA Molecular Typing

A
  • Genotyping

- RT- PCR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

HLA Antibody Testing

A
  • Luminex: Result (CPRA) sent to UNET - Higher number (percentage) means less compatible donor.
  • Flow Cytometric Crossmatch
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Application of HLA testing

A
  • Organ transplantation
  • PLT transfusion
  • TRALI investigation
  • Disease association/treament
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Solid organ Tx vs HSC Tx

A
  • Solid organ: avoid HLA Abs pre-formed from patient

- HSC: HLA matching to avoid GvHD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

HLA & PLT Refractoriness

A
  • When suspicious, pt is tested for HLA class I Abs

- Pt should receive HLA I -negative for that specific Abs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Strategies for “compatible” PLT

A
  • HLA matched PLT
  • Avoid HLA specificities based on Abs
  • PLT XM
  • Acceptable HLA mismatches
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

HLA & TRALI

A
  • Transfusion Induced Lung Injury
  • Donor’s blood has HNA, HLA I, HLA II
  • Activate patient’s HLA activate neutrophils and endothelial cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

HLA Prevention

A
  • Screen for HLA Abs only for female donor donating PLT and AB Plasma
  • Donors positive for HLA Abs will be deferred forever
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

RBC Genotyping vs Phenotyping

A
  • Genotype: RBC antigen predicted by DNA sequence at a particular location on chromosome
  • Phenotype: RBC antigen expressed as determined with serologic method
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Problems with serological typing

A
  • Multiple RBC population
  • Interfering Abs
  • Discrepant results or undetectable underlying genetic differences in blood group Ag
  • No antisera available
  • No sample avaialble
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Indications for RBC genotyping

A
  • Post-transfusion
  • Discrepant serologic results
  • Unable to detect
  • No antisera
  • Interfering Abs
  • No sample (fetus)
  • Zygosity matters
  • Desire to RBC type large number of people
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Acute Immunologic TR

A
  • During or w/in 24hrs of transfusion
  • DAT positive
  • Increase bilirubin; LDH;
  • Decrease: hemoglobin, haptoglobin;
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Acute Non-immunologic TR

A
  • During or w/in 24hrs of transfusion
  • DAT negative - Independent with Abs
  • Asymptomatic; hemoglobinuria
  • Caused by chemical or physical damage (improper shipping & storage)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Delay Immunologic TR

A
  • After 24hrs
  • AbSC switch from neg to pos
  • If DAT positive, perform eluate –> Eluate positive —> Antigen typing units transfused.
  • Other markers of hemolysis: LDH, Total bilirubin, direct bilirubin, haptoglobin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Delay Non-immunologic TR

A
  • After 24hrs

- Independent with Abs

17
Q

Why AHTR so dangerous

A
  • Hypotension and shock
  • Acute renal failure
  • Disseminated coagulopathy and bleeding
18
Q

4 most dangerous (to the health of the patient) transfusion reactions

A
  • Acute hemolytic = intravascular hemolysis
  • TRALI
  • Bacterial contamination (RBCs)
  • Anaphylaxis
19
Q

Why Yersinia enterocolitica dangerous

A
  • Cause RBC contaminated (grow in cold, love heme)
  • Produce endotoxin
  • Come from an asymptomatic donor
20
Q

Organism assoc. with PLT contamination

A

S. aureus and S. epidermis

21
Q

Methods to reduce the chance of bacterial contamination of platelets

A
  • Diversion pouch to remove skin plug

- Bacterial detection test on all PLT

22
Q

Report of transfusion-related deaths to FDA

A

Verbally report by e-mail as soon as possible and in writing by 7 days